Baudax Bio Inc expected to post a loss of $1.27 a share - Earnings Preview

Baudax Bio

01/08/2022 14:32

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 3
(estimated). 
    * The Malvern Pennsylvania-based  company is expected to
report  a
284.6% increase in revenue to $773 thousand from $201 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for a
loss of $1.27 per share. For the same quarter last year, the
company reported a loss of $8.05 per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$8​, above​ its last closing price of $0.70. ​​​

This summary was machine generated August 1 at 13:32 GMT.  All
figures in US dollars  unless otherwise stated